How do we make progress in phenotyping patients with lower urinary tract such as overactive bladder and underactive detrusor, including using urine markers and microbiome data, to personalize therapy? ICI‐RS 2023—Part 2.

MLA

Finazzi Agrò, Enrico, et al. “How Do We Make Progress in Phenotyping Patients with Lower Urinary Tract Such as Overactive Bladder and Underactive Detrusor, Including Using Urine Markers and Microbiome Data, to Personalize Therapy? ICI‐RS 2023—Part 2.” Neurourology & Urodynamics, vol. 43, no. 6, Aug. 2024, pp. 1272–82. EBSCOhost, https://doi.org/10.1002/nau.25379.

APA

Finazzi Agrò, E., Rosato, E., Wagg, A., Sinha, S., Fede Spicchiale, C., Serati, M., Mancini, V., de Rijk, M., Tarcan, T., Wein, A., Abrams, P., & Bou Kheir, G. (2024). How do we make progress in phenotyping patients with lower urinary tract such as overactive bladder and underactive detrusor, including using urine markers and microbiome data, to personalize therapy? ICI‐RS 2023—Part 2. Neurourology & Urodynamics, 43(6), 1272–1282. https://doi.org/10.1002/nau.25379

Chicago

Finazzi Agrò, Enrico, Eleonora Rosato, Adrian Wagg, Sanjay Sinha, Claudia Fede Spicchiale, Maurizio Serati, Vito Mancini, et al. 2024. “How Do We Make Progress in Phenotyping Patients with Lower Urinary Tract Such as Overactive Bladder and Underactive Detrusor, Including Using Urine Markers and Microbiome Data, to Personalize Therapy? ICI‐RS 2023—Part 2.” Neurourology & Urodynamics 43 (6): 1272–82. doi:10.1002/nau.25379.